| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |